4Slatton ML, lrani WN, Hall SA, et al. Does digoxin provide additional hemodynamic and autonomic benefit at higher doses in patients with mild to moderate heart failure and normal sinus rhythm [J]? J Am Coll Cardiol, 1997, 29(9): 1206.
5Braunwald E, Colucci WS, Grossman W. Clinical aspects of heart failure: high-output heart failure; pulmonary edema[A]. In: Braunwald E,eds. Heart disease [M]. W.B. Saunders. Beijing: China Academic Publishers, 1999.452-459.
6Li Y, Shi H, Qi W , et al. Hemodynamic effects following short-time treatment with fructose 1,6-diphosphate in patients congestive heart failure secondary to coronary artery disease [J]. Eur Heart J, 1995, (Suppl): 107.
7Angel KM, Michacl AB, Alfredo F, et al. Hemodynamic effects of fructose 1,6-diphosephate in patients with normal and impaired left ventricular function[J]. Am Heart J,1997,133 (5):541.
8Fu YJ, Zheng DW, Gu JY, et al. Fructose 1,6-diphosphate reduces mortality and improves hemodynamic in patients with congestive heart failure [J]. Eur Heart J,1995, (Suppl): 442.
9Newton GE, Tong JH, Schofield AM, et al. Digoxin rcduces cardiac sympathetic activity in severe congestive heart failure [J]. J Am Coll Cardiol, 1996, 28(2) :151.
10Kang PM, Landau AJ, Eberhardt RT, et al.Angiotensin II receptor antagonists: A new approach to blockade of the reninagiotensin system[J].Am Heart J, 1999, 127:1388-1397.
